Size | Price | Stock | Qty |
---|---|---|---|
25mg |
|
||
50mg |
|
||
100mg |
|
||
250mg |
|
||
500mg |
|
||
1g |
|
||
Other Sizes |
|
Purity: ≥98%
Paeoniflorin (Peoniflorin), a glycoside, is a herbal constituent extracted from the root of Paeonia albiflora Pall. Paeoniflorin has a hypoglycemic effect and has been used as an anticonvulsant. This substance activates the brain's central Adenosine A1-Rs, which reverse the hypotension brought on by guanethidine.
ln Vitro |
Paeoniflorin (80 μg/mL; 4–24 h) treatment can induce Hsp70, Hsp40, and Hsp27[3].
|
---|---|
ln Vivo |
Paeoniflorin (intradermal injection; once daily; 25 and 100 mg/kg) exhibits positive outcomes for experimental arthritic[4].
|
Cell Assay |
Cell Line: HeLa and IMR-32 cells
Concentration: 80 μg/mL Incubation Time: 4, 8, 12, 16, and 24 hours Result: Promoted the phosphorylation of HSF1. |
Animal Protocol |
D rats with collagen induced arthritis
25 and 100mg/kg Intradermal injection; 25 and 100mg/kg; once daily; 20 days |
References |
|
Molecular Formula |
C23H28O11
|
|
---|---|---|
Molecular Weight |
480.46
|
|
Exact Mass |
480.16
|
|
Elemental Analysis |
C, 57.50; H, 5.87; O, 36.63
|
|
CAS # |
23180-57-6
|
|
Related CAS # |
|
|
Appearance |
Solid powder
|
|
SMILES |
C[C@]12C[C@@]3([C@@H]4C[C@]1([C@@]4([C@H](O2)O3)COC(=O)C5=CC=CC=C5)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)O
|
|
InChi Key |
YKRGDOXKVOZESV-WRJNSLSBSA-N
|
|
InChi Code |
InChI=1S/C23H28O11/c1-20-9-22(29)13-7-23(20,32-18-16(27)15(26)14(25)12(8-24)31-18)21(13,19(33-20)34-22)10-30-17(28)11-5-3-2-4-6-11/h2-6,12-16,18-19,24-27,29H,7-10H2,1H3/t12-,13-,14-,15+,16-,18+,19-,20+,21+,22-,23+/m1/s1
|
|
Chemical Name |
[(1R,2S,3R,5R,6R,8S)-6-hydroxy-8-methyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-9,10-dioxatetracyclo[4.3.1.02,5.03,8]decan-2-yl]methyl benzoate
|
|
Synonyms |
Paeoniflorin
|
|
HS Tariff Code |
2934.99.9001
|
|
Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
|
Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
Solubility (In Vitro) |
|
|||
---|---|---|---|---|
Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (5.20 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (5.20 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. View More
Solubility in Formulation 3: ≥ 2.5 mg/mL (5.20 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 2.0813 mL | 10.4067 mL | 20.8134 mL | |
5 mM | 0.4163 mL | 2.0813 mL | 4.1627 mL | |
10 mM | 0.2081 mL | 1.0407 mL | 2.0813 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
NCT Number | Recruitment | interventions | Conditions | Sponsor/Collaborators | Start Date | Phases |
NCT05973097 | Recruiting | Drug: total glucosides of paeony treatment Other: photodynamic therapy treatment |
Oral Lichen Planus | Peking University Third Hospital |
July 30, 2023 | Not Applicable |
NCT02878863 | Withdrawn | Drug: Paeoniflorin + phosphatidylcholine or silymarin |
Hepatitis, Autoimmune | Xiaoli Fan | August 2016 | Phase 3 |
The chemical structure of the main metabolites of paeoniflorin. Biomed Pharmacother . 2020 Oct:130:110505. td> |
Potential application of paeoniflorin. Biomed Pharmacother . 2020 Oct:130:110505. td> |
Molecular targets of paeoniflorin. Biomed Pharmacother . 2020 Oct:130:110505. td> |
Effect of paeoniflorin and glycyrrhizin on the induction of heat shock protein 70 (Hsp70). Cell Stress Chaperones . 2004 Winter;9(4):378-89. td> |
(A) Development of thermotolerance in HeLa cells treated with paeoniflorin and the 960 mixture (containing paeoniflorin). Cell Stress Chaperones . 2004 Winter;9(4):378-89. td> |